Peak6 Investments LLC Repligen Corp Put Options Transaction History

Peak6 Investments LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $416,340 - $529,530	3,000 New	3,000 $477,000
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $324,840 - $441,120	2,000 New	2,000 $339,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $3.26 Million - $4.36 Million	-23,200 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $435,213 - $696,492	-2,700 Reduced 10.42%	23,200 $4.36 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $584,310 - $972,629	-3,000 Reduced 10.38%	25,900 $7.49 Million
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $2.97 Million - $3.96 Million	-17,900 Reduced 38.25%	28,900 $5.77 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $8.44 Million - $10.6 Million	46,800 New	46,800 $9.1 Million
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $473,856 - $661,024	-3,200 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $612,550 - $791,350	-5,000 Reduced 60.98%	3,200 $472,000
Q1 2020 May 14, 2020	SELL	$84.96 - $109.14 $611,712 - $785,808	-7,200 Reduced 46.75%	8,200 $792,000
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $720,720 - $908,138	15,400 New	15,400 $854,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.